glp 1 drugs and inflammation Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control Central glucagon-like peptide 1 receptor

No injections

Adult-onset type 1 diabetes mellitus differs from the early onset form in terms of residual endogenous insulin secretion, comorbidities and baseline cardiorenal risk

The new class of weight-loss medications are hailed as game-changing wonder drugs, but just how safe and effective are they

Do GLP-1 patches really work for weight loss and diabetes

Tirzepatide 15 mg led to higher discontinuation rate of study medication due to adverse events regardless of comparator, while all tirzepatide doses were safe in terms of serious adverse events and mortality

Demand for these drugs has increased rapidly in recent years, as indications have expanded, but they remain expensive